Toggle navigation
Home
Search
Services
Blog
Contact
About
Development and Toxicological Evaluation of Sustained-Re
Medisorb Technologies International, Lp, Cincinnati, OH, United States
Search grants from Medisorb Technologies International, Lp
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
Prevention of type 2 diabetes
Pathogenesis of Facioscapulohumeral Dystrophy
Upgrade of A 4.7t/40cm Ge Omega Csi NMR Spectrometer
Genetic Epidemiology of Seizure Disorders in Rochester
Recently added grants:
Epigenetic Mechanisms in Type 1 Diabetes
Dynamics and Health Consequences of Obesity between Infancy and Young Adulthood in the United States
Vascular ion channels and microcirculation in neonatal urinary tract obstruction
Roles of BCL11A in ?-globin repression
Identification of Novel Bioactive Lipid Metabolites for Predicting Liver-related Outcomes in Persons Co-Infected with HIV and HCV
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research and Development Contracts (N01)
Project #
N01DA029209-000
Application #
2306221
Study Section
Project Start
1992-09-30
Project End
Budget Start
1992-09-30
Budget End
1993-06-15
Support Year
Fiscal Year
1992
Total Cost
Indirect Cost
Institution
Name
Medisorb Technologies International, Lp
Department
Type
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45242
Related projects
NIH 1994
N01 DA
Development and Toxicological Evaluation
Atkins, Thomas J. / Medisorb Technologies International, Lp
NIH 1993
N01 DA
Development and Toxicological Evaluation of Sustained-Re
Atkins, Tom / Medisorb Technologies International, Lp
NIH 1993
N01 DA
Development and Toxicological Evaluation
Atkins, Thomas J. / Medisorb Technologies International, Lp
NIH 1992
N01 DA
Development and Toxicological Evaluation of Sustained-Re
/ Medisorb Technologies International, Lp
Comments
Be the first to comment on this grant